SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-221875
Filing Date
2020-08-17
Accepted
2020-08-17 08:30:59
Documents
4
Period of Report
2020-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d86553d8k.htm 8-K 18618
2 EX-99.1 d86553dex991.htm EX-99.1 69412
3 EX-99.2 d86553dex992.htm EX-99.2 34146
4 GRAPHIC g86553g31x79.jpg GRAPHIC 2946
  Complete submission text file 0001193125-20-221875.txt   127479
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 201108013
SIC: 3841 Surgical & Medical Instruments & Apparatus